Mindray Medical International Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

November 2024 | 50 pages | ID: M0D0A3A74F0BEN
BAC Reports

Abstracts

Mindray Medical International Limited Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Mindray Medical International Limited and its competitors. This provides our Clients with a clear understanding of Mindray Medical International Limited position in the Healthcare Equipment and Supplies Industry.

• The report contains detailed information about Mindray Medical International Limited that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• Another part of the report is a SWOT-analysis carried out for Mindray Medical International Limited. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
• The Mindray Medical International Limited financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
• In the part that describes Mindray Medical International Limited competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Mindray Medical International Limited business.

About Mindray Medical International Limited

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., engages in the development, manufacture, and marketing of medical devices worldwide.

Segments

The company supplies internationally a range of products across three primary business segments: Patient Monitoring and Life Support Products; In-Vitro Diagnostic Products; and Medical Imaging Systems.

Patient Monitoring and Life Support Products

Patient Monitoring Devices: The company’s patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration, and temperature. It offers patient monitoring devices that are suitable for adult, pediatric, and neonatal patients and are used principally in hospital intensive care units, operating rooms. and emergency rooms. The company’s product line offers customers a range of functionality, such as single- and multiple-parameter monitors, mobile and portable multifunction monitors, central stations that can collect and display multiple patient data on a single screen, and an electro-cardiogram monitoring device. Its multi-parameter monitoring devices can be networked, allowing hospitals to remotely gather patient data from patient rooms and centralize that data in a single location. The company’s patient monitoring devices also have built-in recorders and have batteries for portability in various models, as well as power backup in the event of power failure in mobile models. The company also offers a line of veterinary monitoring devices.

Life Support Products: The company also offers a range of its life support products. It offers anesthesia machines and a defibrillator, which it introduced in 2009. The company also introduced surgical beds and surgical lights in 2009.

In-vitro Diagnostic Products

The company’s in-vitro diagnostic products provide data and analysis on blood, urine, and other bodily fluid samples for clinical diagnosis and treatment. It offers a range of semi-automated and automated in-vitro diagnostic products for laboratories, clinics and hospitals to perform analysis to detect and quantify various substances in the patient samples. The company’s product portfolio consists of in-vitro diagnostic products in two primary product categories, hematology analyzers and biochemistry analyzers.

Hematology Analyzers: The company’s hematology analyzers test blood samples to detect abnormalities or foreign substances. Its hematology analyzers can be used to detect blood diseases, such as anemia, and to screen to differentiate between illnesses caused by viruses from those caused by bacteria. The company offers semi-automated and automated three-part differential analyzers and automated five-part differential analyzers (analyzers of three or five different types of white blood cells) with the ability to analyze a range of parameters through the use of reagents.

Biochemistry Analyzers: The company’s biochemistry analyzers measure the concentration or activity of substances, such as enzymes, proteins, and substrates. These analyzers may be used as therapeutic drug monitors or to check for drug abuse. The company’s primary biochemistry analyzer, the BS-200 automated analyzer, can hold approximately 40 samples at a time with approximately 40 reagents, allowing for approximately 200 tests per hour.

The company also offers reagents for use with its in-vitro diagnostic products. A reagent is a substance used in the chemical reactions analyzed by its in-vitro diagnostic products. The company offers approximately 70 reagents for hematology analyzers and 45 reagents for biochemistry analyzers. It also offers reagents that can be used in diagnostic laboratory instruments produced by other international and China-based manufacturers.

Medical Imaging Systems

The company’s medical imaging systems segment includes both ultrasound systems and digital radiography systems. Its ultrasound systems use computer-managed sound waves to produce real time images of anatomical movement and blood flow. Ultrasound systems are commonly employed in medical fields, such as urology, gynecology, obstetrics, and

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. MINDRAY MEDICAL INTERNATIONAL LIMITED COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. MINDRAY MEDICAL INTERNATIONAL LIMITED BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. MINDRAY MEDICAL INTERNATIONAL LIMITED SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. MINDRAY MEDICAL INTERNATIONAL LIMITED FINANCIAL ANALYSIS

4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. MINDRAY MEDICAL INTERNATIONAL LIMITED COMPETITORS AND INDUSTRY ANALYSIS

5.1. Mindray Medical International Limited Direct Competitors
5.2. Comparison of Mindray Medical International Limited and Direct Competitors Financial Ratios
5.3. Comparison of Mindray Medical International Limited and Direct Competitors Stock Charts
5.4. Mindray Medical International Limited Industry Analysis
5.4.1. Healthcare Equipment and Supplies Industry Snapshot
  5.4.2. Mindray Medical International Limited Industry Position Analysis

6. MINDRAY MEDICAL INTERNATIONAL LIMITED NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. MINDRAY MEDICAL INTERNATIONAL LIMITED EXPERTS REVIEW¹

7.1. Experts Consensus
7.2. Experts Revisions

8. MINDRAY MEDICAL INTERNATIONAL LIMITED ENHANCED SWOT ANALYSIS²

9. CHINA PESTEL ANALYSIS²

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. MINDRAY MEDICAL INTERNATIONAL LIMITED IFE, EFE, IE MATRICES²

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. MINDRAY MEDICAL INTERNATIONAL LIMITED PORTER FIVE FORCES ANALYSIS²

12. MINDRAY MEDICAL INTERNATIONAL LIMITED VRIO ANALYSIS²

APPENDIX: RATIO DEFINITIONS

LIST OF FIGURES

Mindray Medical International Limited Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Mindray Medical International Limited 1-year Stock Charts
Mindray Medical International Limited 5-year Stock Charts
Mindray Medical International Limited vs. Main Indexes 1-year Stock Chart
Mindray Medical International Limited vs. Direct Competitors 1-year Stock Charts
Mindray Medical International Limited Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

List Of Tables

LIST OF TABLES

Mindray Medical International Limited Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Mindray Medical International Limited Key Executives
Mindray Medical International Limited Major Shareholders
Mindray Medical International Limited History
Mindray Medical International Limited Products
Revenues by Segment
Revenues by Region
Mindray Medical International Limited Offices and Representations
Mindray Medical International Limited SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Mindray Medical International Limited Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Mindray Medical International Limited Capital Market Snapshot
Mindray Medical International Limited Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment and Supplies Industry Statistics
Mindray Medical International Limited Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Mindray Medical International Limited Consensus Recommendations¹
Analyst Recommendation Summary¹
Price Target Summary¹
Experts Recommendation Trends¹
Revenue Estimates Analysis¹
Earnings Estimates Analysis¹
Historical Surprises¹
Revenue Estimates Trend¹
Earnings Estimates Trend¹
Revenue Revisions¹

ANALYSIS FEATURES

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

• How to use the strengths to take advantage of the opportunities?
• How to use the strengths to reduce likelihood and impact of the threats?
• How to overcome the weaknesses that obstruct taking advantage of the opportunities?
• How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

• Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
• Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
• Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
• Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
• Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
• Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

1. What composes a threat of substitute products and services?
2. Is there a threat of new competitors entering the market?
3. What is the intensity of competitive rivalry?
4. How big is the bargaining power of buyers?
5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

• Tangible resources
  • Financial
  • Physical
  • Technological
  • Organizational
• Intangible resources
  • Human
  • Innovation and Creativity
  • Reputation
• Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

• Valuable?
• Rare?
• Costly to imitate?
• Organized properly?